NDAORAL-28TABLET
Lifecycle
Pre-Launch
Data completeness
0/8 — Limited
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NORLESTRIN FE 2.5/50 is an oral combined hormonal contraceptive tablet containing norethindrone acetate 2.5 mg, ethinyl estradiol 50 mcg, and ferrous fumarate for iron supplementation in a 28-day cycle. It prevents pregnancy through suppression of ovulation and alteration of cervical mucus and endometrial environment. The iron component addresses menstrual blood loss-related anemia in contraceptive users.
Pre-Launch
Pre-launch product with undefined commercial trajectory; career roles will focus on launch infrastructure, market preparation, and regulatory execution rather than established brand management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Joining the NORLESTRIN FE team offers high-visibility pre-launch career opportunity within Pfizer's contraceptive portfolio, with emphasis on market strategy development, healthcare provider engagement, and competitive positioning against entrenched oral contraceptive brands. Success in this launch phase can establish strong portfolio-building credentials, though long-term career growth will be constrained by the mature, commoditized oral contraceptive market.
Brand Manager
Worked on NORLESTRIN FE 2.5/50 at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.